Quantcast
Last updated on April 18, 2014 at 13:38 EDT

Latest Ethers Stories

2014-04-16 23:16:46

Passages Malibu issues statement on the ongoing problem with prescription opioids in the US. Malibu, CA (PRWEB) April 16, 2014 A three-year study of prescription painkillers published March 3rd in the JAMA Internal Medicine revealed that individuals with the highest risk for overdose obtain medication from a doctor’s prescription. The use of opioid painkillers for non-medical reasons has grown substantially over the last decade. Some of the prescription opioids that are misused include...

2014-04-16 16:30:50

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/q7jzmk/sustained_release) has announced the addition of the "Concise Analysis of International Sustained Release Injectables to 2020" [http://www.researchandmarkets.com/research/q7jzmk/sustained_release ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Formulations, Dosing, Devices, Markets and Forecasts The ability...

2014-04-16 04:20:40

DUBLIN, Ireland, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/rw7dl6/methyl_tertiary) has announced the addition of the "Methyl Tertiary Butyl Ether (MTBE): 2014 World Market Outlook and Forecast up to 2018" [http://www.researchandmarkets.com/research/rw7dl6/methyl_tertiary ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Methyl tertiary butyl ether...

2014-04-08 20:21:36

SAN DIEGO, April 8, 2014 /PRNewswire/ -- Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the U.S. Food and Drug Administration (FDA)-approved prescription drug product, Zohydro(TM) ER (hydrocodone bitartrate) extended-release capsules (CII), entered on March 27, 2014, by Massachusetts Governor Deval Patrick. Zogenix appreciates the opportunity to be heard by the court on an expedited basis. A follow-up hearing has been...

2014-04-07 12:32:56

First presentation of detailed BUNAVAIL clinical data scheduled for April 11 and 13, 2014 RALEIGH, N.C., April 7, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that data from clinical studies of BUNAVAIL will be presented at the American Society of Addiction Medicine (ASAM) 45(th) Annual Medical-Scientific Conference, April 10-13, 2014 in Orlando, Florida. Four abstracts will be presented highlighting data from the clinical development...

2014-04-02 08:23:42

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qq54kk/global_and ) has announced the addition of the "Global And Chinese Methyl Tert-Butyl Ether (MTBE) Industry Report 2014" [http://www.researchandmarkets.com/research/qq54kk/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global And Chinese Methyl Tert-Butyl Ether (MTBE) Industry Report 2014 is a...

2014-04-01 08:30:10

Rate of high risk use low among commercially insured ST. PAUL, Minn., April 1, 2014 /PRNewswire/ -- People who are at high-risk for opioid abuse use had significantly higher total medical costs ($19,513 vs. $5,493) than those who were not at high risk according to a new study by Prime Therapeutics (Prime). The Centers for Medicare & Medicare Services (CMS) defines high risk as "using a daily morphine equivalent dose (MED) of greater than 120 mg for at least 90 consecutive days,...

2014-03-31 23:38:49

Passages Malibu issues statement on the prevalence of dependence issues among individuals who have suffered past trauma. Malibu, CA (PRWEB) March 31, 2014 According to a new report analyzing how returning military veterans take pain medication, roughly half of returning military service personnel who were prescribed opioid painkillers continued to use them chronically. The report, funded by the National Institute on Drug Abuse, was presented on March 6th at the annual meeting of the...

2014-03-28 00:23:11

SAN DIEGO, March 27, 2014 /PRNewswire/ -- We agree with Governor Deval Patrick's intention to curb the epidemic of drug abuse in Massachusetts. However, we are extremely concerned by his unprecedented action with respect to a specific FDA-approved prescription medication. We believe Governor Patrick's ban on Zohydro(TM) ER only serves to unfairly restrict patient access to the only hydrocodone pain reliever available for long-term, daily, severe chronic pain patients who are obtaining relief...

2014-03-27 08:34:22

ROSEMONT, Pa., March 27, 2014 /PRNewswire/ -- Duchesnay USA is pleased to announce Kosher and Halal certifications for Diclegis(®) (doxylamine succinate 10mg and pyridoxine hydrochloride -vitamin B(6)- 10mg) delayed-release tablets, the only FDA-approved prescription treatment for nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness. Diclegis also received Kosher for Passover certification and confirmed as gluten, lactose and tartrazine free, making the...